| LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 S Hacein-Bey-Abina, C Von Kalle, M Schmidt, MP McCormack, ... science 302 (5644), 415-419, 2003 | 4261 | 2003 |
| A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency S Hacein-Bey-Abina, C Von Kalle, M Schmidt, F Le Deist, N Wulffraat, ... New England journal of medicine 348 (3), 255-256, 2003 | 2336 | 2003 |
| International network of cancer genome projects Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ... Nature 464 (7291), 993-998, 2010 | 2124 | 2010 |
| Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy N Cartier, S Hacein-Bey-Abina, CC Bartholomae, G Veres, M Schmidt, ... science 326 (5954), 818-823, 2009 | 1603 | 2009 |
| Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients SJ Howe, MR Mansour, K Schwarzwaelder, C Bartholomae, M Hubank, ... The Journal of clinical investigation 118 (9), 2008 | 1331 | 2008 |
| Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 MG Ott, M Schmidt, K Schwarzwaelder, S Stein, U Siler, U Koehl, H Glimm, ... Nature medicine 12 (4), 401-409, 2006 | 1330 | 2006 |
| Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy A Biffi, E Montini, L Lorioli, M Cesani, F Fumagalli, T Plati, C Baldoli, ... Science 341 (6148), 1233158, 2013 | 1237 | 2013 |
| Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome A Aiuti, L Biasco, S Scaramuzza, F Ferrua, MP Cicalese, C Baricordi, ... Science 341 (6148), 1233151, 2013 | 1131 | 2013 |
| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 995 | 2018 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 976 | 2020 |
| Dissecting the genomic complexity underlying medulloblastoma DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ... Nature 488 (7409), 100-105, 2012 | 892 | 2012 |
| Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease S Stein, MG Ott, S Schultze-Strasser, A Jauch, B Burwinkel, A Kinner, ... Nature medicine 16 (2), 198-204, 2010 | 849 | 2010 |
| Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration E Montini, D Cesana, M Schmidt, F Sanvito, M Ponzoni, C Bartholomae, ... Nature biotechnology 24 (6), 687-696, 2006 | 839 | 2006 |
| COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ... Nature biotechnology 38 (8), 970-979, 2020 | 795 | 2020 |
| Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector HB Gaspar, KL Parsley, S Howe, D King, KC Gilmour, J Sinclair, G Brouns, ... The Lancet 364 (9452), 2181-2187, 2004 | 794 | 2004 |
| Murine leukemia induced by retroviral gene marking Z Li, J Dullmann, B Schiedlmeier, M Schmidt, C Von Kalle, J Meyer, ... Science 296 (5567), 497-497, 2002 | 793 | 2002 |
| Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma DTW Jones, B Hutter, N Jäger, A Korshunov, M Kool, HJ Warnatz, ... Nature genetics 45 (8), 927-932, 2013 | 731 | 2013 |
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ... Cancer cell 25 (3), 393-405, 2014 | 716 | 2014 |
| An unbiased genome-wide analysis of zinc-finger nuclease specificity R Gabriel, A Lombardo, A Arens, JC Miller, P Genovese, C Kaeppel, ... Nature biotechnology 29 (9), 816-823, 2011 | 680 | 2011 |
| The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy E Montini, D Cesana, M Schmidt, F Sanvito, CC Bartholomae, M Ranzani, ... The Journal of clinical investigation 119 (4), 964-975, 2009 | 635 | 2009 |
